That's cool. Thank you to slick and to msf. No, I was not meaning to express that I would get rid of it. I understand that every year cannot be a great one. Most of my other stuff is with TRP in a rollover 401k, and my PRWCX stake is becoming a problem due to its own SUCCESS. It's already about one-third of my entire portfolio, now. I might look for a TRP International small-cap offering, then. Good idea. :)

I don't know how to get access to the institutional share class OSMYX of Oppenheimer Int'l Small Company without going through a plan (e.g. 401(k)) or advisor, but you can purchase load-waived A shares OSMAX NTF though a variety of brokers (Fidelity, TDAmeritrade, etc.).

I'm not unhappy with my own small-cap: MSCFX Mairs and Power. It was flying high and on fire in '13, but not so much, now. Someone in here referred to it as "aggressive." (Ted?) I put profit from it into its big sister, MAPOX. Also just plain lackluster this year. But I hear there's a lotta THAT going around this year, in 2015.

@MSF
ALFAX is available at Scottrade in taxable/nontaxable accounts (with 5.75% load) for minimum investment of $1,500.00 with subsequent investment minimums of $100.00.
ALFYX is available at Scottrade through an advisor for an initial minimum of $1M.

found this on DMCRX:
http://www.bizjournals.com/prnewswire/press_releases/2013/11/18/CG18400

FYI: Investors continue to pump money into markets where central bankers have their feet on the gas pedals.
Meanwhile, they’re pumping the brakes on emerging-market and commodities.
Regards,
Ted
http://blogs.barrons.com/focusonfunds/2015/07/30/japan-and-europe-funds-continue-to-rake-assets/tab/print/

FYI, there is a lower minimum of $2000 for DRMCX and DRESX when buying in an IRA, at least at TDAmeritrade (both funds) and Vanguard (only DRESX is available). Given their high turnover, you would probably want to keep these funds in a tax-advantaged account.
DRESX was profiled by David last year here: http://www.mutualfundobserver.com/2014/03/driehaus-emerging-markets-small-cap-growth-fund-dresx-march-2014/

Market breath peaked in April 1998 before the major decline began in March 2000. And back then it was just a handful of tech stocks that accounted for the big gains in late 98 to the final top. Not sure when breath peaked this time around. The next large decline could be led by the biotechs even if there is no similarity between them in this cycle vs tech stocks in the late 90s cycle. Anyone looked at the chart of Biogen (BIIB) lately?

Sort of Ted but by going to the horses mouth (THE WSJ) we learned about Disney ). Still your right in that this is a key issue worthy of informing visitors to this site. Who knows two posts might help make a greater impression. I am not selling yet but historically this is an early (possibly too early predictor of a drop. At the very least right or wrong I am not buying the dips till 15%

http://www.wsj.com/articles/the-only-six-stocks-that-matter-1437942926
All the gains in the S+P 500 could be associated with 6 stocks

@Jerry: http://www.marketwatch.com/story/shed-no-tears-for-departed-funds-2009-12-27
It finally died, but not without tears of fears and years of tears.

too lazy to check whether the Steadman funds still exist (obviously not under the same name !0+ years since this link
http://articles.baltimoresun.com/2002-04-14/business/0204130137_1_steadman-funds-account-activity

Skill or luck? Good results are attributable to my skill. Bad results are attributable to my associate's luck. Some funds that M* says are 'World Allocation' include MALOX (always love that ticker), IVAEX, RPGAX, TIBIX, APPLX, GBMFX and TZINX. These are all VERY different. This is one category that seems to be a catch-all for those funds M* doesn't know what to do with them. U.S. equity is anywhere from 19% to almost 50%. Bonds from 4% to 36%. Non-U.S. equity from 22% to 52%. YTD returns all over the place too, from -2.5% to +4.6%. Some are holding sizeable cash, others almost none. Some have specific mandates, others no restrictions. A case could be made to add others to this list, like FPACX and WHGIX. The take-away might be that "world allocation" can be a lot of things.

That's right, DMCRX has only been available since the end of 2013 for retail investors. The CAGR going back to 1996 is wild, something like 22%
The fund seems to follow a momentum strategy from what I could see on their website.

not much of a track record yet, but I've been happy with DMCRX.

(I was writing up my post and didn't see this.)
M* gives a ten year record for this fund, and since the source of the table was M*, I didn't look more closely - I just assumed that IBD mechanically used M*'s data.
You are right that the fund does not have a ten year record. It prepended the record of its predecessor fund, Driehaus Emerging Markets Small Cap Growth Fund, L.P. As the prospectus notes, that predecessor fund was not registered as a mutual fund (1940 Act), so it was playing under different rules.

Sold LINE.

Uh, rather good call on that....
http://blogs.barrons.com/incomeinvesting/2015/07/30/linn-energy-there-goes-the-dividend/?mod=yahoobarrons&ru=yahoo

Why a table of 13 funds? That's a pretty odd number, not to mention unlucky.
Should Triton be on the list, or should one follow the managers (to Meridian Growth and Small Cap Growth funds)? And since they listed Triton, how about listing Janus Venture, formerly managed by the same team of Meade/Schaub (though its 10 year performance is about 0.10% below the bottom of the 13 fund list)?
Note - the Meridian funds have not done well since the managers moved there.
In the same performance ballpark as Venture one finds Wasatch Micro Cap Value (WAMVX) - it's open and its average market cap is smaller than any of the other funds on the list.
Speaking of microcaps, where's Driehaus Micro Cap Growth (DMCRX), whose 10 year performance would rank #2, just behind Lord Abbett Micro Cap Growth (and just ahead of Triton)? It's open, has a $10K min, and is available NTF at a few brokerages.
Getting back to the tail end of the table, another fund that just misses the cutoff is Lord Abbett Alpha Strategies I. Mortals can't buy that ($1M min), but the A shares (ALFAX) are available load-waived at various brokerages. Since it's a fund of funds, it's a way to buy into Lord Abbett Micro Cap Growth I, which is at the top of the list.
Maybe if IBD increased the size of its list to 17, we'd have more good options. That might work for Fox News, too :-)

@Ted
After looking at the 7/29/15 prospectus, there is no mention in it that the Tweedy, Browne Global Value Fund II - Currency Unhedged is closed. That is why the supplement, dated 7/29/15 indicates that the fund is closed.
Too bad it was not included in the prospectus in the first place.
7/29/15 Prospectus:
http://www.sec.gov/Archives/edgar/data/896975/000119312515267402/d948002d485bpos.htm

FYI: Seven of the 10 highest paid chief executives on Wall Street last year came from the asset-management industry.
Regards,
Ted
http://blogs.barrons.com/focusonfunds/2015/07/30/asset-management-ceos-top-wall-street-compensation-ranks/tab/print/

I added HDPSX about a year ago, holds less than 100 stocks. Although it has grown to $2B in assets, still has 75% in microcap and small cap stocks. Can be volatile, as many small cap funds are, with higher than average standard deviation, but its return compensates for this increased volatility. Initial purchase 1k. open to all investors.